These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19486996)

  • 1. Reversal of cardiac dysfunction after enzyme replacement in patients with infantile-onset Pompe disease.
    Chen LR; Chen CA; Chiu SN; Chien YH; Lee NC; Lin MT; Hwu WL; Wang JK; Wu MH
    J Pediatr; 2009 Aug; 155(2):271-5.e2. PubMed ID: 19486996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series.
    Wang LY; Ross AK; Li JS; Dearmey SM; Mackey JF; Worden M; Corzo D; Morgan C; Kishnani PS
    Paediatr Anaesth; 2007 Aug; 17(8):738-48. PubMed ID: 17596219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.
    van der Beek NA; Hagemans ML; van der Ploeg AT; Reuser AJ; van Doorn PA
    Acta Neurol Belg; 2006 Jun; 106(2):82-6. PubMed ID: 16898258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring cardiac function by B-type natriuretic peptide (BNP) in patients with infantile Pompe's disease treated with recombinant alpha-glucosidase.
    Hahn A; Schmidt D; Hagel KJ; Neubauer BA; Katz N
    Clin Lab; 2006; 52(11-12):615-9. PubMed ID: 17175893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study.
    Klinge L; Straub V; Neudorf U; Voit T
    Neuropediatrics; 2005 Feb; 36(1):6-11. PubMed ID: 15776317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enzyme replacement therapy in a boy with infantile Pompe disease: cardiac follow-up].
    Bonnefoy R; Labarthe F; Paoli F; Chantreuil J; Barthez MA; Froissart R; Poinsot J; Chantepie A
    Arch Pediatr; 2008 Dec; 15(12):1760-4. PubMed ID: 18995995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pompe disease in infants: improving the prognosis by newborn screening and early treatment.
    Chien YH; Lee NC; Thurberg BL; Chiang SC; Zhang XK; Keutzer J; Huang AC; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
    Pediatrics; 2009 Dec; 124(6):e1116-25. PubMed ID: 19948615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial.
    Klinge L; Straub V; Neudorf U; Schaper J; Bosbach T; Görlinger K; Wallot M; Richards S; Voit T
    Neuromuscul Disord; 2005 Jan; 15(1):24-31. PubMed ID: 15639117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease.
    Kishnani PS; Hwu WL; Mandel H; Nicolino M; Yong F; Corzo D;
    J Pediatr; 2006 May; 148(5):671-676. PubMed ID: 16737883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease.
    Levine JC; Kishnani PS; Chen YT; Herlong JR; Li JS
    Pediatr Cardiol; 2008 Nov; 29(6):1033-42. PubMed ID: 18661169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease.
    An Y; Young SP; Kishnani PS; Millington DS; Amalfitano A; Corz D; Chen YT
    Mol Genet Metab; 2005 Aug; 85(4):247-54. PubMed ID: 15886040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy.
    Ebbink BJ; Aarsen FK; van Gelder CM; van den Hout JM; Weisglas-Kuperus N; Jaeken J; Lequin MH; Arts WF; van der Ploeg AT
    Neurology; 2012 May; 78(19):1512-8. PubMed ID: 22539577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pompe's disease. Part II. Treatment strategies and enzyme replacement].
    Illés Z; Várdi Visy K
    Ideggyogy Sz; 2009 Sep; 62(9-10):299-307. PubMed ID: 19835271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alglucosidase alfa: new drug. Pompe disease: a short-term benefit.
    Prescrire Int; 2007 Dec; 16(92):240-1. PubMed ID: 18092404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaesthetic management of infants with glycogen storage disease type II: a physiological approach.
    Ing RJ; Cook DR; Bengur RA; Williams EA; Eck J; Dear Gde L; Ross AK; Kern FH; Kishnani PS
    Paediatr Anaesth; 2004 Jun; 14(6):514-9. PubMed ID: 15153218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The earliest enzyme replacement for infantile-onset Pompe disease in Japan.
    Tocan V; Mushimoto Y; Kojima-Ishii K; Matsuda A; Toda N; Toyomura D; Hirata Y; Sanefuji M; Sawada T; Sakai Y; Nakamura K; Ohga S
    Pediatr Int; 2022 Jan; 64(1):e15286. PubMed ID: 36074069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both type 1 and type 2a muscle fibers can respond to enzyme therapy in Pompe disease.
    Drost MR; Schaart G; van Dijk P; van Capelle CI; van der Vusse GJ; Delhaas T; van der Ploeg AT; Reuser AJ
    Muscle Nerve; 2008 Feb; 37(2):251-5. PubMed ID: 17894362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzyme replacement therapy in Pompe's disease].
    Merk T; Wibmer T; Schumann C; Krüger S
    Med Klin (Munich); 2007 Jul; 102(7):570-3. PubMed ID: 17634875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease.
    McDowell R; Li JS; Benjamin DK; Morgan C; Becker A; Kishnani PS; Kanter RJ
    Genet Med; 2008 Oct; 10(10):758-62. PubMed ID: 18813140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pompe's disease: the role for early diagnosis and treatment].
    Cerini E; Bini M; Donati A; Andaloro L; Compagnoni G
    Pediatr Med Chir; 2007; 29(5):270-2. PubMed ID: 18402397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.